The changing landscape of naloxone availability in the United States, 2011 – 2017

According to the Centers for Disease Control and Prevention (CDC, 2017a), opioid overdose deaths have been on a steady incline since 1999. In fact, nationwide age-adjusted rates of opioid overdose deaths increased more than five-fold between 1999 and 2016. Naloxone, first approved by the Food and Drug Administration in 1971, is a competitive opioid antagonist that can rapidly reverse opioid overdose. Evidence suggests that communities with naloxone access have lower rates of opioid overdose deaths (Walley et al., 2013).

Source: Drug and Alcohol Dependence - August 30, 2018 Category: Addiction Authors: Patricia R. Freeman, Emily R. Hankosky, Michelle R. Lofwall, Jeffery C. Talbert Tags: Short communication Source Type: research